Moving at warp speed: Are you ready to go to market?

The current model for biotech companies often means operating in drastically compacted timelines. This focus on speed can lead to complications or oversight of important regulatory and...

Introduction to Drug, Biologics, and Biosimilars Law and Regulation

Scott Kaplan presented the segment titled "Regulation of Manufacturing" at the Food and Drug Law Institute's Introduction to Drug, Biologics, and Biosimilars Law and Regulation course.

ACI's FDA Boot Camp (New York)

Scott Kaplan presented on the topic "Understanding FDA Enforcement and Authority and Actions" at the 33rd American Conference Institute's (ACI) FDA Boot Camp in New York.

Loading data